Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin B.

ABSTRACT: The polymyxin lipodecapeptides colistin and polymyxin B have become last resort therapies for infections caused by highly drug-resistant Gram-negative bacteria. Unfortunately, their utility is compromised by significant nephrotoxicity and polymyxin-resistant bacterial strains. We have conducted a systematic activity-toxicity investigation by varying eight of the nine polymyxin amino acid free side chains, preparing over 30 analogues using a novel solid-phase synthetic route. Compounds were tested against a panel of Gram-negative bacteria and counter-screened for in vitro cell toxicity. Promising compounds underwent additional testing against primary kidney cells isolated from human kidneys to better predict their nephrotoxic potential. Many of the new compounds possessed equal or better an

SUBMITTER: Gallardo-Godoy A 

PROVIDER: S-EPMC4774972 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature